跳至主要内容
临床试验/NCT03535610
NCT03535610已完成不适用

Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.

Scitech Produtos Medicos Ltda2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2018年8月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
2
主要终点
Uterine Volume Reduction

研究概览

简要总结

To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • female patients from 18 to 50 years old;
  • symptomatic uterine intramural leiomyomas or multiple symptomatic leiomyomas in the presence of intramural;
  • patient agrees with study procedures;
  • patient signs the informed consent form.

排除标准

  • asymptomatic women;
  • isolated adenomyosis, pediculated subserous myoma, submucous leiomyoma (50% of uterine cavity diameter), intraligamentous leiomyoma;
  • leiomyoma diameter higher than 10 cm;
  • leiomyoma above the umbilical scar;
  • endometrial neoplasia or hyperplasia or presence of any malignancy
  • pregnant or breast feeding women;
  • active vasculitis;
  • pelvic irradiation history;
  • uncontrolled coagulopathies;
  • renal insufficiency;
  • contrast allergy;
  • concomitant use of GnRH analogues.

结局指标

主要结局

Uterine Volume Reduction

时间窗: 6 months

Uterine Volume Reduction measured by MRI

Fibroid Reduction

时间窗: 6 months

Fibroid Reduction measured by MRI

次要结局

  • Ovarian Function(6 months)
  • Quality of Life Improvement(6 months)

研究者

发起方
Scitech Produtos Medicos Ltda
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验